Vergoeding 2019-2023 voor ATC-subgroep L04AA : Selectieve immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022* | 2023* | |
|---|---|---|---|---|---|
| L04AA03 Lymfocytenimmunoglobuline | . | . | . | 54.674 | 669.360 |
| L04AA04 Thymocytenimmunoglobuline | . | . | . | 399.622 | 1.246.130 |
| L04AA24 Abatacept | 18.594.154 | 18.397.041 | 18.594.962 | 18.268.140 | 20.317.897 |
| L04AA28 Belatacept | 943.841 | 1.039.979 | 1.120.084 | 1.221.558 | 1.442.694 |
| L04AA32 Apremilast | 4.461.070 | 4.221.344 | 4.357.292 | 4.059.212 | 3.900.122 |
| L04AA41 Imlifidase | . | . | . | 323.730 | 323.730 |
| Totaal | 23.999.065 | 23.658.364 | 24.072.338 | 24.326.936 | 27.899.934 |